Survival after liver transplantation in the United Kingdom and Ireland compared with the United States

Gut

Volumn 56, Issue 11, 2007, Pages 1606-1613

  Dawwas, M F ^a   Gimson, A E ^a   Lewsey, J D ^b   Copley, L P ^b   Van Der Meulen, J H P ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HUMAN; IRELAND; LIVER FAILURE; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; GREAT BRITAIN; HOSPITAL MORTALITY; HUMANS; IRELAND; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; UNITED STATES;

EID: 35648943178     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.111369     Document Type: Article

References (59)

1. Quam L, Smith R. What can the UK and US health systems learn from each other? BMJ 2005;330:530-3.
2. Bennett-Guerrero E, Hyam JA, Shaefi S, et al. Comparison of P-POSSUM risk-adjusted mortality rates after surgery between patients in the US and the UK. Br J Surg 2003;90:1593-8.
3. Anyanwu AC, Rogers CA, Murday AJ. Variations in cardiac transplantation: comparisons between the United Kingdom and the United States. J Heart Lung Transplant 1999;18:297-303.
4. Stell DA, McAlister VC, Thorburn D. A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States. Liver Transpl 2004;10:898-902.
5. Roberts MS, Angus DC, Bryce CL, et al. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004;10:886-97.
6. Jacob M, Copley LP, Lewsey JD, et al. UK and Ireland Liver Transplant Audit. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004;10:903-907.
7. Dickinson DM, Bryant PC, Williams MC, et al. Transplant data: sources, collection, and caveats. Am J Transplant 2004;4(Suppl 9):13-26.
8. Daily OP, Kauffman HM. Quality control of the OPTN/UNOS transplant registry. Transplantation 2004;77:1309.
9. Kremers WK, van IJperen M, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004;39:764-9.
10. Russo MW, Galanko JA, Shrestha R, et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004;10:1018-23.
11. Barshes NR, Lee TC, Balkrishnan R, et al. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation 2006;81:195-201.
12. United Network for Organ Sharing. Available at: http://www.unos.org. Accessed August 2007.
13. Moreau T, Le Minor M, Myquel P, et al. Estimation of the hazards ratio in two grouped samples. Biometrics 1985;41:245-52.
14. Royston P. Multiple imputation of missing values. Stata J 2004;4:227-241.
15. Royston P. Multiple imputation of missing values: update. Stata J 2005;5:1-14.
16. Edwards EB, Roberts JP, McBride MA, et al. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med 1999;341:2049-53.
17. Northup PG, Pruett TL, Stukenborg GJ, et al. Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. Am J Transplant 2006;6:2455-62.
18. Panageas KS, Schrag D, Riedel E, et al. The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med 2003;139:658-65.
19. Levine GN, McCullough KP, Rodgers AM, et al. Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant 2006;6:1228-42.
20. Jacob M, Lewsey JD, Sharpin C, et al. Systematic review and validation of prognostic models in liver transplantation. Liver Transpl 2005;11:814-25.
21. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-90.
22. Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77:99-106.
23. Narayanan Menon KV, Nyberg SL, Harmsen WS, et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004;4:819-25.
24. Institute of Medicine. Analysis of waiting times. In: Committee on Organ Transplantation Assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academy Press, 1999:57-78.
25. Freeman RB Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 2000;6:543-52.
26. Northup PG, Berg CL. Preoperative delta-MELD score does not independently predict mortality after liver transplantation. Am J Transplant 2004;4:1643-9.
27. Bilbao I, Armadans L, Lazaro JL, et al. Predictive factors lor early mortality following liver transplantation. Clin Transplant 2003;17:401-11.
28. Merion RM, Guidinger MK, Newmann JM, et al. Prevalence and outcomes of multiple-listing for cadaveric kidney and liver transplantation. Am J Transplant 2004;4:94-100.
29. Axelrod DA, Guidinger MK, McCullough KP, et al. Association of center volume with outcome after liver and kidney transplantation. Am J Transplant 2004;4:920-7.
30. Lankshear AJ, Sheldon TA, Maynard A. Nurse staffing and healthcare outcomes: a systematic review of the international research evidence. Adv Nurs Sci 2005;28:163-74.
31. Aiken LH, Clarke SP, Sloane DM, et al. Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA 2002;288:1987-93.
32. Audit Commission. Critical to success: the place of efficient and effective critical care services within the acute hospital. London: Audit Commission, 1999.
33. Edbrooke D, Hibbert C, Corcoran M. An international perspective: review for the NHS Executive of Adult Critical Care Services, Medical Economics & Research Centre, Sheffield (MERCS), August, 1999.
34. Holpern NA, Pastores SM, Greenstein RJ. Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs. Crit Care Med 2004;32:1254-9.
35. Kause J, Smith G, Prytherch D, et al., Intensive Care Society (UK); Australian and New Zealand Intensive Care Society Clinical Trials Group. A comparison of antecedents to cardiac arrests, deaths and emergency intensive care admissions in Australia and New Zealand, and the United Kingdom - the ACADEMIA study. Resuscitation 2004;62:275-82.
36. Goldfrad C, Rowan K. Consequences of discharges from intensive care at night. Lancet 2000;355:1138-42.
37. Tarnow-Mordi WO, Hau C, Warden A, et al. Hospital mortality in relation to staff workload: a 4-year study in an adult intensive-care unit. Lancet 2000;356:185-9.
38. Grocott MPW, Ball JAS. Consensus meeting: management of the high risk surgical patient. Clin Intensive Care 2000;11:263-281.
39. National Confidential Enquiry into Perioperative deaths. Then and now: the 2000 report of the National Confidential Enquiry into Perioperative Deaths (1 April 1998 to 31 March 1999). London: NCEPOD, 2000.
40. Daly K, Beale R, Chang RW. Reduction in mortality after inappropriate early discharge from intensive care unit: logistic regression triage model. BMJ 2001;322:1274-6.
41. National Confidential Enquiry into Perioperative deaths. The 2002 report of the National Confidential Enquiry into Perioperative Deaths (1 April 2000 to 31 March 2001). London: NCEPOD, 2002.
42. Sinuff T, Kahnamoui K, Cook DJ, Luce JM, Levy MM, Values Ethics and Rationing in Critical Care Task Force. Rationing critical care beds: a systematic review. Crit Care Med 2004;32:1588-97.
43. Imber CJ, St Peter SD, Lopez I, et al. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl 2002;8:545-9.
44. Imber G, St Peter SD, Handa A, et al. Hepatic steatosis and its relationship to transplantation. Liver Transpl 2002;8:415-23.
45. Rull R, Vidal O, Momblan D, et al. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl 2003;9:389-93.
46. Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500-5.
47. Salizzoni M, Franchello A, Zamboni F, et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003;16:486-93.
48. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003;9:651-63.
49. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-45.
50. Reuben A. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl 2001;7(11 Suppl 1):S13-21.
51. Starfield B, Shi L. Policy relevant determinants of health: an international perspective. Health Policy 2002;60:201-18.
52. Macinko J, Starfield B, Shi L. The contribution of primary care systems to health outcomes within Organization for Economic Cooperation and Development (OECD) countries, 1970-1998. Health Serv Res 2003;38:831-65.
53. Blendon RJ, Schoen C, DesRoches C, et al. Common concerns amid diverse systems: health care experiences in five countries. Health Aff (Millwood) 2003;22:106-21.
54. Banks J, Marmot M, Oldfield Z, et al. Disease and disadvantage in the United States and in England. JAMA 2006;295:2037-45.
55. Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl 2004;10:235-43.
56. Woodward RS, Schnitzler MA, Lowell JA, et al. Effect of extended coverage of immunosuppressive medications by Medicare on the survival of cadaveric renal transplants. Am J Transplant 2001;1:69-73.
57. Yen EF, Hardinger K, Brennan DC, et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004;4:1703-8.
58. Kim SJ, Schaubel DE, Fenton SS, et al. Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant 2006;6:109-14.
59. Welsh FK, Wigmore SJ. Roux-en-Y Choledochojejunostomy is the method of choice for biliary reconstruction in liver transplantation for primary sclerosing cholangitis. Transplantation 2004;77:602-4.